Skip to content

Study Evaluating the Effectiveness of Treatment With Vista Care®, in Arterial Ulcers of the Lower Extremities

Study Evaluating the Effectiveness of Treatment With Vista Care®, in Arterial Ulcers of the Lower Extremities

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05133570
Acronym
VISTA CARE
Enrollment
12
Registered
2021-11-24
Start date
2021-10-29
Completion date
2023-10-29
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Heal

Brief summary

The prevalence of chronic wounds is around 2 million people in France per year. A chronic wound is a wound that has been evolving for more than 6 weeks. The main causes are: venous causes, arterial causes and microcirculatory causes. In some aetiologies (particularly arterial causes), there is no radical therapeutic solution (no possibility of revascularisation) and the wounds are often difficult to treat and may even eventually lead to amputation. The recommendations for treating wounds are (in addition to carrying out an etiological treatment when possible) to carry out mechanical detersion and to maintain a moist wound environment. In addition to various medical devices such as dressings, adjuvant treatments that are not specific to the etiology of the wound, such as electrotherapy, negative pressure therapy or other devices such as the VistaCare®, are indicated in France.

Detailed description

Prospective, open-label, multi-centre study evaluating the performance of the VistaCare® wound healing device in routine practice.

Interventions

DEVICEvista care

Prospective, open-label, multi-centre study evaluating the performance of the VistaCare® wound healing device in routine practice.

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* -Patient able and willing to comply with the requirements of the including hospitalization for up to 15 days. * Patient whose wound to be studied is located in a location compatible with the use of VistaCare®, namely the leg including the knee but excluding the upper thigh * Agreement of the study no-objection form * Age greater than or equal to 18 years * Patient affiliated to a social security scheme

Exclusion criteria

* -Patient with general signs of infection at the time of inclusion (fever, lymphangitis, pus ...). Patient with active smoking Subject under guardianship or deprived of liberty Failure to obtain patient consent

Design outcomes

Primary

MeasureTime frame
Evaluation of the healing performance of the VistaCare® device in routine practice in patients with chronic arterial leg wounds.2 years

Countries

France

Contacts

Primary Contactsophie blaise, MD PhD
SBlaise@chu-grenoble.fr33476765547
Backup Contactfatima bouchafa, CRA
33476765547

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026